Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
8,97 USD | +5,04 % | +86,10 % | +78,69 % |
30/04 | Les actions de Wallstreetbets sont majoritairement en baisse avant le marché ; MicroStrategy et Tesla en baisse | MT |
29/04 | IMMUNITYBIO, INC. : Piper Sandler confirme sa recommandation neutre | ZM |
Métier
Nombre d'employés: 628
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Richard Adcock
CEO | Chief Executive Officer | 55 | 01/10/20 |
Founder | 71 | 01/12/14 | |
David Sachs
DFI | Director of Finance/CFO | 46 | 01/07/19 |
Leonard Sender
COO | Chief Operating Officer | - | 01/03/20 |
John Lee
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/03/19 |
Sandeep K. Reddy
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/20 |
Hans Klingemann
CTO | Chief Tech/Sci/R&D Officer | 74 | - |
Enrique Dilone
CTO | Chief Tech/Sci/R&D Officer | 57 | 14/08/23 |
Barry Simon
BRD | Director/Board Member | 69 | 01/01/07 |
- | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Founder | 71 | 01/12/14 | |
Cheryl L. Cohen
BRD | Director/Board Member | 58 | 01/06/19 |
Wesley Clark
BRD | Director/Board Member | 78 | 24/02/21 |
Director/Board Member | 69 | 01/08/20 | |
Barry Simon
BRD | Director/Board Member | 69 | 01/01/07 |
Michael Blaszyk
BRD | Director/Board Member | 71 | 01/07/15 |
Richard Adcock
CEO | Chief Executive Officer | 55 | 01/10/20 |
John Brennan
BRD | Director/Board Member | 67 | 24/02/21 |
Linda Maxwell
BRD | Director/Board Member | 50 | 29/03/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 677 200 211 | 140 112 265 ( 20,69 %) | 163 800 ( 0,0242 %) | 20,69 % |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+78,69 % | 5,78 Md | |
-1,65 % | 104 Md | |
+6,75 % | 97,47 Md | |
+5,71 % | 22,25 Md | |
-12,60 % | 21,68 Md | |
-9,70 % | 18,2 Md | |
-39,98 % | 17,02 Md | |
-10,17 % | 16,36 Md | |
+6,12 % | 14,39 Md | |
+35,47 % | 12,37 Md |
- Bourse
- Actions
- Action IBRX
- Société ImmunityBio, Inc.